News
FDA Finalizes Guidance on Weight-Loss Devices
8+ hour, 34+ min ago (103+ words) The U. S. Food and Drug Administration (FDA) has released its Final Guidance on pre-market submission considerations for medical devices intended for uses associated with weight loss. As a reminder, FDA guidance documents do not establish legally enforceable requirements or responsibilities and…...
Kelun-Biotech Approved by HKEX to Remove 'B' Marker from Stock Code, Representing a New Stage of Development
1+ hour, 38+ min ago (339+ words) The Manila Times - Accelerated product approvals and significant time-to-market efficiency: Within three years since its listing, Kelun-Biotech has already secured approvals for 4 products across 8 indications, among which 3 products with 5 indications have been included in China's National Reimbursement Drug List (NRDL),…...
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Autologous Cell Therapy Market
1+ hour, 51+ min ago (56+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....
FDA Directed For Strict Action Against Defaulters
39+ min ago (467+ words) Faizan Hashmi Published April 09, 2026 | 05: 00 PM FAISALABAD, (Urdu Point / Pakistan Point News - 9th Apr, 2026) Director General (DG) Faisalabad Development Authority (FDA) Muhammad Asif Chaudhary has directed for strict legal action against defaulters and said that the properties of those who fail to…...
Pharmaceutical Customized R&D and Production Services Market
57+ min ago (47+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....
Key Players and Competitive Overview in the Cell and Gene Therapy Manufacturing Services Market
1+ hour, 9+ min ago (72+ words) open PR. com Key Players and Competitive Overview in the Cell and Gene Therapy Manufacturing Services Market Press release from: The Business Research Company Cell & Gene Therapy Manufacturing Services Market Permanent link to this press release: You can edit or…...
Cell Therapy and Gene Therapy CDMO Market Is Booming Rapidly with Strong Demand By 2033| Lonza " Wu Xi App Tec " Catalent
54+ min ago (71+ words) Cell Therapy and Gene Therapy CDMO Market Is Booming Rapidly with'open PR. com Cell Therapy and Gene Therapy CDMO Market Is Booming Rapidly with Strong Demand By 2033| Lonza " Wu Xi App Tec " Catalent Press release from: Coherent Market Insights Permanent…...
Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders
1+ hour, 40+ min ago (120+ words) April 09, 2026 7: 00 AM EDT | Source: Sernova Biotherapeutics At the Meeting, a total of 93, 246, 234 common shares were voted, representing 27. 31% of the votes attached to all outstanding common shares of the Company as of the record date of February 17, 2026. In addition, all other…...
Bioretec Ltd. Rights 2026-21. 04. 26 For Shares Bioretec Rg I26 Financial Statements " OMXHEX: BRETECU0126 " Trading View
2+ hour, 12+ min ago (154+ words) Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. It specializes in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The company's products include bioabsorbable nails, pins, and…...
Cartography Biosciences Advances Strategic Oncology Collaboration with Gilead's First Option Target Exercise
1+ hour, 10+ min ago (239+ words) " Novel oncology target identified by Cartography ATLAS and SUMMIT platforms " " Milestone underscores strength of platform and advances collaboration pipeline " The option exercise represents a key milestone in the companies" multi-year strategic collaboration to discover and develop therapies against novel tumor-selective…...